| Viread(R) for Hepatitis B Maintains Antiviral Suppression with No Development ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Both Viread and Truvada were well tolerated, and no unexpected or clinically important adverse events related to renal function were reported among these ... read more |